The existence of lymphoid lineage restricted Philadelphia chromosome-positive acute lymphoblastic leukemia with heterogeneous bcr-abl rearrangement

被引:0
|
作者
L Pajor
JA Vass
L Kereskai
P Kajtár
Á Szomor
M Egyed
J Iványi
P Jáksó
机构
[1] University Medical School of Pécs,Department of Pathology
[2] University Medical School of Pécs,Department of Pediatrics
[3] University Medical School of Pécs,Department of 1st Internal Medicine
[4] Kaposi Mór Hospital,Department of Internal Medicine
[5] Markusovszky Hospital,Department of Hematology
来源
Leukemia | 2000年 / 14卷
关键词
Philadelphia chromosome; lymphoblastic leukemia; lineage involvement;
D O I
暂无
中图分类号
学科分类号
摘要
Analysis of lineage involvement was performed in 17 Philadelphia chromosome-positive acute lymphoblastic leukemia patients with no history of chronic myeloproliferative disorder. The percentage of blastic cells as defined by flow cytometry matched that of the Ph-positive cells in 14 out of 17 patients. The bcr-abl rearrangement was investigated by fluorescent in situhybridization in morphologically identified blastic cells, myeloid elements, lymphocytes and erythroblasts using a combined light and fluorescent microscopical imaging. Lymphoid lineage restriction could be determined in all but three of the patients. These 14 patients exhibited heterogeneity in terms of m-bcr and M-bcr types of translocation as revealed by reverse transcription polymerase chain reaction. The three patients with multilineage involvement and M-bcr type of translocation reverted to chronic phase and the percentage of Ph-positive cells remained high. Thus, we could identify an uncommitted stem cell origin among Ph-positive ALLs only in those patients whose disease subsequently proved to be a lymphoid blastic crisis with clinically silent chronic phase.
引用
收藏
页码:1122 / 1126
页数:4
相关论文
共 50 条
  • [41] Philadelphia chromosome-positive acute lymphoblastic leukemia in Taiwan
    B.-S. Ko
    J.-L. Tang
    W. Tsai
    Y.-C. Chen
    C.-H. Wang
    M.-C. Sheng
    D.-T. Lin
    K.-H. Lin
    H.-F. Tien
    Annals of Hematology, 2001, 80 : 510 - 515
  • [42] Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Iman Abou Dalle
    Elias Jabbour
    Nicholas J. Short
    Farhad Ravandi
    Current Treatment Options in Oncology, 2019, 20
  • [43] RAPSYN-mediated neddylation of BCR-ABL alternatively determines the fate of Philadelphia chromosome-positive leukemia
    Zhao, Mengya
    Dai, Beiying
    Li, Xiaodong
    Zhang, Yixin
    Qiao, Chun
    Qin, Yaru
    Li, Zhao
    Li, Qingmei
    Wang, Shuzhen
    Yang, Yong
    Chen, Yijun
    ELIFE, 2024, 12
  • [44] Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia or Chronic Myeloid Leukemia in Lymphoid Blast Crisis
    Kolenova, Alexandra
    Maloney, Kelly W.
    Hunger, Stephen P.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2016, 38 (06) : E193 - E195
  • [45] Leptomycin B overcomes imatinib resistance mediated by stromal cells and mutant BCR-ABL in Philadelphia chromosome-positive acute lymphoblastic leukemia cells.
    Tojo, A
    Izawa, K
    Sekine, R
    Nagamura, T
    Yoshida, M
    Tsuji, T
    BLOOD, 2004, 104 (11) : 575A - 575A
  • [46] Complete phenotypic and genotypic lineage switch in a Philadelphia chromosome-positive acute lymphoblastic leukemia
    Pane, F
    Frigeri, F
    Camera, A
    Sindona, M
    Brighel, F
    Martinelli, V
    Luciano, L
    Selleri, C
    DelVecchio, L
    Rotoli, B
    Salvatore, F
    LEUKEMIA, 1996, 10 (04) : 741 - 745
  • [47] CHIMERIC BCR-ABL MESSENGER-RNA AS A MARKER FOR MINIMAL RESIDUAL DISEASE IN PATIENTS TRANSPLANTED FOR PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA
    GEHLY, GB
    BRYANT, EM
    LEE, AM
    KIDD, PG
    THOMAS, ED
    BLOOD, 1991, 78 (02) : 458 - 465
  • [48] A novel BCR-ABL1 mutation in a patient with Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia
    Vinhas, Raquel
    Lourenco, Alexandra
    Santos, Susana
    Lemos, Marcos
    Ribeiro, Patricia
    de Sousa, Aida Botelho
    Baptista, Pedro Viana
    Fernandes, Alexandra Ramos
    ONCOTARGETS AND THERAPY, 2018, 11 : 8589 - 8598
  • [49] IMPLICATING THE BCR/ABL GENE IN THE PATHOGENESIS OF PHILADELPHIA CHROMOSOME-POSITIVE HUMAN LEUKEMIA
    DALEY, GQ
    BEN-NERIAH, Y
    ADVANCES IN CANCER RESEARCH, 1991, 57 : 151 - 184
  • [50] Dynamic Prediction of Outcome with Longitudinal BCR-ABL1 Levels in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Sasaki, Koji
    Kantarjian, Hagop
    Richard-Carpentier, Guillaume
    Ravandi, Farhad
    Short, Nicholas
    Garcia-Manero, Guillermo
    Daver, Naval
    Kadia, Tapan
    Konopleva, Marina
    Jain, Nitin
    Issa, Ghayas
    Jeanis, Vicki
    Alvarez, Joie
    Khouri, Maria
    Nasnas, Patrice
    Garris, Rebecca
    Wierda, William
    Thompson, Philip
    Pemmaraju, Naveen
    Cortes, Jorge
    O'Brien, Susan
    Jabbour, Elias
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S180 - S181